A detailed history of Rowland & CO Investment Counsel transactions in Amgen Inc stock. As of the latest transaction made, Rowland & CO Investment Counsel holds 18,115 shares of AMGN stock, worth $5.83 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares
18,115
Previous 18,405 1.58%
Holding current value
$5.83 Million
Previous $5.75 Million 1.5%
% of portfolio
1.2%
Previous 1.26%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$309.38 - $337.38 $89,720 - $97,840
-290 Reduced 1.58%
18,115 $5.84 Million
Q2 2024

Jul 29, 2024

SELL
$262.75 - $319.31 $81,452 - $98,986
-310 Reduced 1.66%
18,405 $5.75 Million
Q1 2024

Apr 08, 2024

SELL
$268.87 - $324.56 $20,434 - $24,666
-76 Reduced 0.4%
18,715 $5.32 Million
Q4 2023

Jan 03, 2024

SELL
$255.7 - $288.46 $7,671 - $8,653
-30 Reduced 0.16%
18,791 $5.41 Million
Q3 2023

Oct 26, 2023

SELL
$218.65 - $271.46 $19,459 - $24,159
-89 Reduced 0.47%
18,821 $5.06 Million
Q2 2023

Aug 04, 2023

SELL
$214.27 - $253.37 $13,927 - $16,469
-65 Reduced 0.34%
18,910 $4.2 Million
Q1 2023

Apr 25, 2023

SELL
$225.79 - $275.2 $69,317 - $84,486
-307 Reduced 1.59%
18,975 $4.59 Million
Q4 2022

Jan 04, 2023

BUY
$229.03 - $291.01 $81,305 - $103,308
355 Added 1.88%
19,282 $0
Q3 2022

Oct 06, 2022

BUY
$224.46 - $253.15 $1,122 - $1,265
5 Added 0.03%
18,927 $4.27 Million
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $6,921 - $7,702
-30 Reduced 0.16%
18,922 $4.6 Million
Q1 2022

Apr 26, 2022

SELL
$219.27 - $242.57 $123,229 - $136,324
-562 Reduced 2.88%
18,952 $4.58 Million
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $11,733 - $13,428
59 Added 0.3%
19,514 $4.39 Million
Q3 2021

Nov 08, 2021

BUY
$212.27 - $248.7 $23,349 - $27,357
110 Added 0.57%
19,455 $4.14 Million
Q1 2021

May 11, 2021

SELL
$221.91 - $258.6 $25,519 - $29,739
-115 Reduced 0.59%
19,345 $4.81 Million
Q4 2020

Feb 11, 2021

BUY
$216.38 - $257.67 $41,328 - $49,214
191 Added 0.99%
19,460 $4.47 Million
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $43,644 - $48,536
-186 Reduced 0.96%
19,269 $4.9 Million
Q2 2020

Aug 10, 2020

BUY
$197.81 - $242.74 $36,792 - $45,149
186 Added 0.97%
19,455 $4.59 Million
Q1 2020

May 11, 2020

SELL
$182.24 - $241.7 $121,007 - $160,488
-664 Reduced 3.33%
19,269 $3.91 Million
Q4 2019

Jan 28, 2020

BUY
$189.21 - $243.2 $167,450 - $215,232
885 Added 4.65%
19,933 $4.81 Million
Q3 2019

Oct 02, 2019

BUY
$174.11 - $208.62 $80,438 - $96,382
462 Added 2.49%
19,048 $3.69 Million
Q2 2019

Jul 09, 2019

BUY
$166.7 - $195.41 $29,172 - $34,196
175 Added 0.95%
18,586 $0
Q1 2019

Apr 10, 2019

BUY
$180.87 - $203.88 $17,544 - $19,776
97 Added 0.53%
18,411 $0
Q4 2018

Feb 12, 2019

SELL
$178.4 - $208.25 $41,032 - $47,897
-230 Reduced 1.24%
18,314 $3.57 Million
Q3 2018

Oct 22, 2018

SELL
$185.29 - $208.89 $31,128 - $35,093
-168 Reduced 0.9%
18,544 $0
Q2 2018

Jul 11, 2018

SELL
$166.05 - $186.51 $73,892 - $82,996
-445 Reduced 2.32%
18,712 $0
Q1 2018

Apr 17, 2018

SELL
$169.43 - $198.0 $41,510 - $48,510
-245 Reduced 1.26%
19,157 $0
Q4 2017

Jan 11, 2018

BUY
$168.79 - $188.59 $50,637 - $56,577
300 Added 1.57%
19,402 $0
Q3 2017

Oct 11, 2017

SELL
$167.29 - $191.0 $87,325 - $99,702
-522 Reduced 2.66%
19,102 $0
Q3 2017

Oct 11, 2017

BUY
$167.29 - $191.0 $3.28 Million - $3.75 Million
19,624
19,624 $0

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Rowland & CO Investment Counsel Portfolio

Follow Rowland & CO Investment Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rowland & CO Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Rowland & CO Investment Counsel with notifications on news.